Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
Galderma completed its previously announced cash tender offer for shares of CollaGenex at $16.60 per share, acquiring 21 million shares (97%) for about $349 million (see BioCentury, March 3). Galderma...